Skip to main content

Anna Tate Riegel


Professor of Oncology and Pharmacology


Breast Cancer
General profile




Univ. Leeds U.K. (First Class Honors) B.S. 1978 Pharmacology
Univ. Leeds U.K. (with distinction) M.S. 1979 Steroid Endocrinology
University of Wisconsin, McArdle Lab Ph.D. 1983 Oncology

Honors & Other Special Scientific Recognition
1980-1982 Fulbright Scholar
1982 James Price Award for Cancer Research
1982-1983 Madison Graduate School Fellow, University of Wisconsin
1984-1985 Damon Runyon-Walter Winchell Post-Doctoral Research Fellow
1990-1992 Pharmaceutical Manufacturer’s Association Foundation Junior Faculty Development Award
1992-1997 Research Career Development Award, NIH

Professional Societies
1991 Member, American Endocrine Society
2002 Member, American Association of Cancer Research

Patents filed/granted
1998 “Use of FGF-BP gene promoter sequences as sensors of drug effects and oncogenic, angiogenic vascular and immune function.” Violaine K. Harris, Anton Wellstein and Anna T. Riegel
Provisional PCT/US99/16544; international 014749.0104

2002 “Coactivators in the diagnosis and treatment of breast cancer.”
Anna T. Riegel, Ronald Reiter and Anton Wellstein, filed.


Download cv.doc


  • PhD (1983) University of Wisconsin, Oncology
  • MS (1979) University of Leeds, UK, Steroid Endocrinology
  • BS (1978) University of Leeds, UK, Pharmacology